%A Zhu,Zhong-zhong %A Zhang,Guanglin %A Liu,Jianping %D 2022 %J Pathology and Oncology Research %C %F %G English %K biomarker,prognosis,gastric cancer,treatment response,necroptosis %Q %R 10.3389/pore.2022.1610641 %W %L %M %P %7 %8 2022-September-15 %9 Hypothesis & Theory %# %! A prognostic signature in GC %* %< %T Establishment of a Novel Prognostic Prediction Model for Gastric Cancer Based on Necroptosis-Related Genes %U https://www.por-journal.com/articles/10.3389/pore.2022.1610641 %V 28 %0 JOURNAL ARTICLE %@ 1532-2807 %X Background: Necroptosis plays a crucial role in the progression of multiple types of cancer. However, the role of necroptosis in gastric cancer (GC) remains unclear. The aim of this study is to establish a necroptosis-related prediction model, which could provide information for treatment monitoring.Methods: The TCGA-STAD cohort was employed to establish a prognostic prediction signature and the GEO dataset was employed for external validation. The correlation between the risk score and the immune landscape, tumor mutational burden (TMB), microsatellite instability (MSI), as well as therapeutic responses of different therapies were analyzed.Results: We constructed a prognostic model based on necroptosis-associated genes (NAGs), and its favorable predictive ability was confirmed in an external cohort. The risk score was confirmed as an independent determinant, and a nomogram was further established for prognosis. A high score implies higher tumor immune microenvironment (TIME) scores and more significant TIME cell infiltration. High-risk patients presented with lower TMB, and low-TMB patients had worse overall survival (OS). Meanwhile, Low-risk scores are characterized by MSI-high (MSI-H), lower Tumor Immune Dysfunction and Exclusion (TIDE) score, and higher immunogenicity in immunophenoscore (IPS) analysis.Conclusion: The developed NAG score provides a novel and effective method for predicting the outcome of GC as well as potential targets for further research.